Union’s Horesh Purchases 33% of Super-Pharm

The chain is currently in a challenging retail environment, due both to increasing regulation and to competition

Send in e-mailSend in e-mail
Israeli pharmacy chain, Super-Pharm.
Israeli pharmacy chain, Super-Pharm.Credit: Eyal Toueg

Businessman George Horesh, the controlling shareholder of Union, is buying 33% of the Super-Pharm pharmacy chain at a 1.7 billion shekel ($476 million) valuation.

Horesh will be paying 560 million shekels to Leumi Bank, Discount Bank and Super-Pharm controlling shareholder Leon Koffler. Union has business in the fields of vehicles, retail and real estate.

To really understand Israel and the Middle East - subscribe to Haaretz

Leumi Partners, the non-financial investment arm of Bank Leumi, bought 20% of Super-Pharm’s shares in 2007, and currently holds 15% of the pharmacy chain. The bank is due to receive 250 million shekels for its portion of the shares, and will earn 75 million in profits before tax. Discount Bank’s non-financial investment arm Discount Capital bought its shares in 2013, and holds 10% of the chain’s shares.

Union has retail operations in Israel abroad, and is the official importer for Toyota and H&M in Israel.

Super-Pharm is currently in a challenging retail environment, due both to increasing regulation and to competition. Grocery chain Super-Sol bought competing pharmacy chain Nu-Pharm and rebranded it as Be, making it into a more powerful, more professional competitor that Nu-Pharm was under the ownership of its previous owner, department store chain Hamashbir 365 Holdings.

Super-Pharm is thought to have annual sales turnover of 5 billion shekels in Israel as of 2018, and another 760 million shekels in Poland. Its EBITDA last year was 250 million shekels, and its net profit was 110 million shekels.

Comments